Correction: Nine months of bedaquiline, linezolid, levofloxacin, clofazimine, and cycloserine chemotherapy for rifampicin/multidrug-resistant tuberculosis: a multicenter, randomized, open-label non-inferiority trial in China

BMC Med. 2024 Oct 15;22(1):465. doi: 10.1186/s12916-024-03694-4.
No abstract available

Publication types

  • Published Erratum